Introduction
============

The human gut is heavily populated by a diverse microbial community (gut microbiota) which plays a crucial role in maintaining human health through, e.g., polysaccharide digestion, metabolite and vitamin production, maturation of the immune system and protection against pathogens (for a review, see [@B38]). The adult gut microbiota is dominated by members of Firmicutes and Bacteroidetes phyla although organisms from the Actinobacteria, Verrucomicrobia and Proteobacteria phyla also contribute to the structure and function of this microbial community. The microbiota composition varies longitudinally along the gastrointestinal tract but also transversally from the lumen to the mucosa ([@B11]). The colon is the most densely colonized part of the gut, reaching density of 10^11^--10^12^ cells per gram. The lumen of the gut is generally considered to host a microbial community which is distinct from that of the mucus layer although partial mixing and dispersal by host factors tend to homogenize the community ([@B21]; [@B39]). Several factors influence the biogeography of symbiotic bacteria within the gut, including the gradient and availability of glycans within discrete physical niches ([@B16]).

In the colon, bacteria have access to non-digestible polysaccharides from the diet but also to complex oligosaccharides from the host mucins ([@B16]; [@B35]). It is commonly accepted that diet is the main contributing factor influencing the structure of the gut microbial community in the colon (for a review, see [@B13]). Dietary alteration in the gut microbiota profile can be temporal (e.g., [@B10]) or long-term (e.g., [@B34]). One of the largest single source of energy for microbial growth in the human colon is dietary starch that escapes digestion in the upper gut and reaches the colon undigested. The fermentation of these substrates provides nutrients for the gut bacteria and short-chain fatty acids (SCFAs). SCFAs are beneficial for colon health; they are a source of energy for the colonocytes and contribute to the maintenance of gut barrier function, the protection against colorectal cancer development and the control of intestinal inflammation ([@B13]).

Ruminococcaceae are an important family of Firmicutes bacteria within the colonic microbial communities which have evolved specialized systems to utilize complex carbohydrates. This is in contrast to *Bacteroides* which have been shown to display diverse and versatile glycan metabolizing capabilities (for a recent review, see [@B27]). Members of the genus *Ruminococcus* have been reclassified into three genera and families based on 16S rRNA sequencing, *Blautia* (Lachnospiraceae), *Ruminococcus* (Ruminococcaceae) and *Clostridium* (Clostridiaceae) ([@B18]). *R. bromii* is one of the most abundant bacteria constituting the human colonic microbiota and a primary degrader of RS, an important non-digestible dietary polysaccharide ([@B45], [@B46]). *Ruminoccocus gnavus* was first assigned as a novel species in 1976 ([@B24]) and recently reclassified into genus *Blautia* which belongs to *Clostridium* cluster XIVa, a member of the Lachnospiraceae family but still maintaining its original name ([@B17]). *R. bromii* and *R. gnavus* are prevalent species of the human gut; They are among the 57 species detected in more than 90% of human fecal samples by metagenomic sequencing ([@B30]). The median abundances of *R. bromii* L2-63 and *R. gnavus* are around 3 and 0.1%, respectively ([@B30]). In our previous work we showed that *R. gnavus* ability to grow on host mucin glycoproteins was strain dependent ([@B8], [@B9]), underscoring the importance of analyzing glycan utilization by members of the human gut microbiota at the strain level. The mucin-degrading strain *R. gnavus* ATCC 29149 utilizes mucin glycan epitopes from the intestinal mucus layer as energy source ([@B8], [@B9]).

It has been proposed that the primary role played by *R. bromii* is to release energy from RS to other members of the microbial community ([@B45]). Trophic interactions between members of the microbiota encompass both cooperation and competition. For example, mucin cross-feeding has been reported between gut microbiota species such as infant bifidobacteria and *Eubacterium hallii* ([@B4]) or *Akkermansia muciniphila* and non-mucus-degrading bacteria *Anaerostipes caccae*, *Eubacterium hallii*, or *Faecalibacterium prausnitzii* ([@B2]; [@B7]). Examples of cross-feeding have also been reported within the *Bifidobacterium* genus ([@B23]; [@B41]), and in the presence of primary degraders of RS (with *R. bromii*) or xylan (with *B. ovatus*) ([@B40], [@B42]; [@B32]; [@B5]).

Here, we investigated the molecular mechanisms underpinning the trophic interactions between the human gut symbionts *R. bromii* and *R. gnavus* on host mucin and dietary starch using a combination of bioinformatics, quantitative PCR (qPCR), NMR-based metabolite profiling and RNA-Seq based transcriptomics of mono- and co-cultures.

Materials and Methods {#s1}
=====================

Materials
---------

D-glucose (Glc), type III pig gastric mucin (PGM), maltose, maltotriose and soluble potato starch (SS) were purchased from Sigma-Aldrich (St Louis, MO, United States). Purified pig gastric mucin (pPGM) was prepared as previously described ([@B14]). Maltotetraose was obtained from Carbosynth (Berks, United Kingdom). A retrograded type-III RS derived from high amylose maize was kindly provided by Ingredion (Manchester, United Kingdom).

Bacterial Strains and Growth Conditions
---------------------------------------

*Ruminococcus gnavus* ATCC 29149 was routinely grown in an anaerobic cabinet (Don Whitley, Shipley, United Kingdom) in Brain Heart Infusion broth supplemented with yeast extract and hemin (BHI-YH) as previously described ([@B8]). *R. bromii* L2-63 was also grown in an anaerobic cabinet, in anaerobic basal Yeast extract-Casitone-Fatty Acids (YCFA) medium ([@B12]) supplemented with 0.5% SS. Growth of both bacteria on single carbon sources utilized YCFA medium supplemented with 0.5% (wt/vol) of Glc or starch (SS or RS), malto-oligosaccharides at a concentration of 27.7 mM Glc units, or 1% (wt/vol) pPGM. The growth assays were performed in 96-well plates with 200 μL of medium/well for screening or in 14 mL-tubes with 10 mL medium/tube for sampling. Growth was determined spectrophotometrically by monitoring changes in optical density (OD) at 595 nm or 600 nm compared to the same medium without bacterium (ΔOD~600~ ~nm~) hourly for the first 10 h and then at distinct times up to 75 h. Sampling for DNA extraction, RNA extraction or ^1^H NMR was carried out over growth.

DNA Extraction and qPCR
-----------------------

For the isolation of *R. gnavus* ATCC 29149 and/or *R. bromii* L2-63 chromosomal DNA, cells from a 2 mL-aliquot of culture were harvested by centrifugation (10,000 g, 5 min, 4°C), at different times of growth. The cell pellet was kept frozen at −20°C until DNA extraction. The DNA extraction was carried out using Gene JET Genomic DNA Purification kit (ThermoFisher Scientific) following the supplier's procedure for Gram-positive bacteria, except for the elution step which was performed with 100 μL of EB buffer instead of 200 μL. DNA quality and quantity were assessed using the NanoDrop^TM^ 2000 spectrophotometer (ThermoFisher Scientific) and the Qubit dsDNA HS assay on Qubit^®^ 2.0 fluorometer (ThermoFisher Scientific). Dilutions at 10 ng/μL were prepared in water then the DNA was diluted further in 5 μg/ml Salmon Sperm DNA to obtain a 1 ng/μL dilution used as template for qPCR (see below).

The 16S rRNA genes of *R. gnavus* ATCC 2949 and *R. bromii* L2-63 were amplified with universal primers 27F (5″- AGAGTTTGATCMTGGCTCAG- 3″) and RP2 (5″-ACGGCTACCTTGTTACGACTT-3″). The PCR products were purified, quantified and diluted in water to 16.4 ng/μL which equals to 10^10^ copies/μL. A series of 10-fold or 20-fold dilutions was then performed from 10^10^ copies/μL to 10^2^ copies/2 μL using 5 μg/mL Salmon Sperm DNA. Calibration curves were prepared in triplicates for each pair of primers using 10^7^ copies/2 μL to 10^2^ copies/2 μL dilutions of 16S PCR products. The standard curves showed a linear relationship of log input 16S copy number vs. the threshold cycle (C~T~), with acceptable values for the slopes and the regression coefficients (R^2^). The dissociation curves were also performed to verify the specificity of the amplicons.

Quantitative PCR was carried out in an Applied Biosystems 7500 Real-Time PCR system (Life Technologies Ltd). Three pairs of primers targeting 16S rRNA gene were used in this study (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Each qPCR reaction (10 μL) was then carried out in triplicates with 2 μL of DNA matrix at 1ng/μL and 0.2 mM of each primer, using the QuantiFast SYBR Green PCR kit (Qiagen) according to supplier's advice (except for the combined annealing/extension step which was extended to 35 s instead of 30 s).

RNA Extraction, Ribodepletion and RNA-Seq
-----------------------------------------

Total RNA was extracted from 5 mL of mid- to late exponential phase cultures of *R. gnavus* ATCC 29149 and/or *R. bromii* L2-63 in YCFA supplemented with a single carbon source (Glc, SS or RS). Four biological replicates were performed for each carbon source. The RNA was stabilized prior to extraction by adding 1/5 vol of phenol (pH 4.3): ethanol (1:9) mixture to 1 vol of culture then incubating 30 min on ice and finally pelleting the cells for 5 min at 10,000 g at 4°C. Cell pellets were stored at −80°C before extraction. The extraction was performed by a method using phenol and chloroform and adapted from [@B33]. Genomic DNA contamination was removed by DNAse treatment using the TURBO DNA-free kit (Life Technologies Ltd., Paisley, United Kingdom) according to the supplier's recommendations. The purity, quantity and integrity of the DNase-treated RNA were assessed with NanoDrop 2000 Spectrophotometer and with Agilent RNA 600 Nano kit on Agilent 2100 Bioanalyzer (Agilent Technologies, Stockport, United Kingdom). Ribodepletion was then carried out using Ribo-Zero rRNA Removal kit for bacteria according to supplier's advice (Illumina, Cambridge, United Kingdom); efficiency assessment of the ribodepletion was performed by quantifying RNA before and after rRNA removal using the Qubit RNA HS assay on Qubit 2.0 fluorometer.

The rRNA removal was confirmed with a Nano chip run on a Bioanalyzer 2100 (Agilent). Three out of the four replicates were selected for sequencing for each condition. The resulting ribosomal depleted RNA was then fragmented for 8 min at 94°C using the Elute, Fragment, Prime buffer from Illumina TruSeq RNA kit. These conditions produced final libraries of around 370 bp. The samples were then processed following the standard TruSeq RNA protocol. The 15 Illumina libraries were normalized and equimolar pooled to 11 nM using elution buffer (Qiagen) and run over two lanes of the Illumina HiSeq2500 with a 100 bp paired end read metric.

The library pool was then diluted to 2 nM with NaOH and 5 μL transferred into 995 μL HT1 (Illumina) to give a final concentration of 10 pM. A portion (120 μL) of the diluted library pool was then transferred into a 200 μL-strip tube, spiked with 1% PhiX Control v3 and placed on ice before loading onto the Illumina cBot. The flow cell was clustered using a HiSeq PE Cluster Kit v3 (Illumina PE-401-3001) utilizing the Illumina PE_HiSeq_Cluster_Kit_V3_cBot_recipe_V8.0 method on the Illumina cBot. Following the clustering procedure, the flow-cell was loaded onto the Illumina HiSeq2500 instrument following the manufacturer's instructions with a 101 cycle paired reads and a 7-cycle index read. The sequencing chemistry used was HiSeq SBS Kit v3 (Illumina FC-401-3001) with HiSeq Control Software 2.2.68 and RTA 1.18.66.3. Reads in bcl format were demultiplexed based on the 6 bp Illumina index by CASAVA 1.8, allowing for a one base-pair mismatch per library, and converted to FASTQ format by bcl2fastq. The RNA-Seq reads were aligned against the combined reference of *Ruminococcus_bromii*\_l2_63.ASM20987v1.31.dna.genome.fa and *Ruminococcus_gnavus*\_atcc_29149.ASM16947v1.31.dna.genome.fa using tophat v2.1.0 with the --max-multihits 1 option. Read counts were obtained using htseq-count v0.6.1^[1](#fn01){ref-type="fn"}^. The differential expression analysis was carried out using the DESeq2 (v1.14.0) package ([@B20]). The transcript counts were used as input for DESeq2 and filtered to remove any transcripts with a total count of 0 or 1 over all the samples. Raw counts were normalized to the effective library size separately for *R. bromii* and *R. gnavus* before carrying out the differential expression analysis using the DESeq function. An padj cut-off of 0.05 was used to determine differential expressed transcripts.

^1^H Nuclear Magnetic Resonance Analysis (^1^H NMR)
---------------------------------------------------

^1^H NMR analysis was used to identify the presence, absence, and concentration of several metabolites in the bacterial growth medium of mono- and co-cultures. The spent media were thawed at room temperature and prepared for ^1^H NMR spectroscopy by mixing 400 μL of spent medium with 200 μL of phosphate buffer (0.26 g NaH~2~PO~4~ and 1.41 g K~2~HPO~4~) made up in 100% D~2~O (100 mL), containing 0.1% NaN~3~ (100 mg), and 1 mM sodium 3-(Trimethylsilyl)-propionate-*d*4, (TSP; 17 mg) as a chemical shift reference. The samples were mixed, and 500 μL was transferred into a 5-mm NMR tube for spectral acquisition. The ^1^H NMR spectra were recorded at 600 MHz on a Bruker Avance spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany) running Topspin 2.0 software and fitted with a cryoprobe and a 60-slot autosampler. Each ^1^H NMR spectrum was acquired with 512 scans, a spectral width of 12300 Hz and an acquisition time of 2.7 s and delay time of 3 s. The "noesygppr1d" presaturation sequence was used to suppress the residual water signal with a low-power selective irradiation at the water frequency during the recycle delay. Spectra were transformed with a 0.3-Hz line broadening, manually phased, baseline corrected, and referenced by setting the TSP methyl signal to 0 ppm. Metabolites were identified using information found in the Human Metabolome Database^[2](#fn02){ref-type="fn"}^ and by use of the 2D-NMR methods, COZY, HSQC, and HMBC. The metabolites were quantified using the software Chenomx NMR suite 7.6^TM^.

Bioinformatics Analysis
-----------------------

Genome mining was performed manually by BLAST using the "align two or more sequences" tool ([@B3]). For each target protein, the query sequence used was the reference protein sequence from NCBI; when no reference protein sequence was available, a sequence from a member of the Clostridiales order was used (Supplementary Table [S2](#SM1){ref-type="supplementary-material"}). The subject sequences were the sequences corresponding to all putative proteins from *R. bromii* L2-63 or *R. gnavus* ATCC 29149 genomes. The search for NanA, E and K in *R. bromii* L2-63 was performed according to Almagro-Moreno and Boyd ([@B1]).

Results and Discussion
======================

*R. gnavus* Utilizes Starch Degradation Products Released by *R. bromii*
------------------------------------------------------------------------

The trophic interactions between *R. bromii* L2-63 and *R. gnavus* ATCC 29149 on host and dietary carbon sources were determined under anaerobic conditions using YCFA as a suitable minimum medium for both strains ([@B12]). The growth of *R. bromii* L2-63 and *R. gnavus* ATCC 29149 in mono- or co-cultures was first monitored spectrophotometrically using mucin as sole carbon source. While *R. gnavus* could utilize this substrate, as previously reported ([@B8])*, R. bromii* was unable to grow on mucin as sole carbon source and no growth benefit was observed on this substrate in the presence of *R. gnavus* (Figure [1A](#F1){ref-type="fig"}). Mucin degradation by bacteria relies on the expression of glycoside hydrolases (GHs)^2^ ([@B19]) such as sialidases (GH33), α-fucosidases (GH29, GH95), exo- and endo-β-N-acetylglucosaminidases (GH84 and GH85), β-galactosidases (GH2, GH20, GH42), α-N-acetylglucosaminidases (GH89), endo-β1,4-galactosidases (GH98) or α-N-acetylgalactosaminidases (GH101 and GH129) ([@B35]). We previously showed that the ability of *R. gnavus* to grow on mucin was dependent on the expression of a GH33 intramolecular *trans*-sialidase ([@B8], [@B9]; [@B36]) and that fucose was released from mucin by the action of GH29 and GH95 fucosidases ([@B8]). In contrast, the *R. bromii* L2-63 genome encodes a small number of GHs ([@B25]) compared to *R. gnavus* ATCC 29149 ([@B8]) (21 in *R. bromii* L2-63 vs. 60 in *R. gnavus* ATCC 29149) and no genes encoding mucin-degrading enzymes were found, in line with the inability of this strain to grow on mucin. In addition, its lack of growth in co-culture with *R. gnavus*, suggests that *R. bromii* cannot utilize the monosaccharides released by *R. gnavus*, in agreement with genomic data suggesting that *R. bromii* does not harbor genes involved in fucose or sialic acid metabolism (Supplementary Figures [S1](#SM1){ref-type="supplementary-material"}, [S2](#SM1){ref-type="supplementary-material"}).

![Growth curves of the mono- and co-cultures with mucin **(A)**, soluble starch (SS) **(B)** or resistant starch (RS) **(C)** as sole carbon source and cell concentrations in the different growth conditions **(D)**. The concentrations were determined by qPCR and expressed as 16S rDNA copy number/mL of culture. The values are averages of 3 replicates for *R. gnavus* ATCC 29149 grown with Glc or 4 replicates for the other conditions. The error bars correspond to the standard deviations. Cells samples were collected at a time of growth of 7 h for *R. gnavus* ATCC 29149 grown on Glc, 10 h for *R. bromii* L2-63 grown on SS and 8 h for the other conditions.](fmicb-09-02558-g001){#F1}

*Ruminococcus bromii* L2-63 is highly specialized in starch degradation, dedicating 15 of its 21 GH-encoding genes to putative GH13 amylases ([@B44]). Some of these GH13 amylases revealed an organization in "amylosome", contributing to *R. bromii* exceptional ability to degrade dietary RS ([@B44]; [@B25]). Here we showed that *R. bromii* was able to utilize both starch substrates (SS and RS) as sole carbon source, in agreement with previous reports ([@B45], [@B44]) whereas no growth was detected with *R. gnavus* on these substrates despite the presence of 9 GH13-encoding genes in *R. gnavus* ATCC 29149 genome. Furthermore, while *R. bromii* growth on SS reached ΔOD~600~ ~nm~ of ∼0.8--1, after 12 h of growth, the presence of *R. gnavus* increased the density of cells to ΔOD~600~ ~nm~ ∼ 4 after 10 h, suggesting cross-feeding activity (Figure [1B](#F1){ref-type="fig"}). Due to the presence of insoluble RS particles, the OD~600~ ~nm~ measurements of *R. bromii* grown on RS result in a two-stage curve reflecting both bacterial growth and bacterial degradation of the RS particles. When *R. gnavus* and *R. bromii* were co-cultured with RS, a different profile was observed (Figure [1C](#F1){ref-type="fig"}), suggesting that cross-feeding also occurs on RS, as confirmed below.

To further assess the behavior of *R. bromii* L2-63 and *R. gnavus* ATCC 29149 on starch (SS or RS), the bacteria were quantified by determining 16S rDNA copies per mL of culture by qPCR (Figure [1D](#F1){ref-type="fig"}). The average 16S rDNA copies of *R. bromii* when grown in mono- or co-cultures with RS after 8 h was 7.3 × 10^8^ and 5.6 × 10^8^ per mL of culture, respectively. When SS was used as the carbon source, *R. bromii* 16S rDNA copies per mL of culture was 1 × 10^9^ after 10 h in mono-culture and 5.8 × 10^8^ after 8 h in co-culture with *R. gnavus.* These analyses indicate that the presence of *R. gnavus* did not affect *R. bromii* growth on starch (RS or SS). *R. gnavus* reached high concentration level in both SS and RS co-cultures with 16S rDNA copies/mL of 6.7 × 10^8^ and 1.2 × 10^9^, respectively, while it was not able to grow in mono-culture on these substrates, confirming that *R. gnavus* benefits from *R. bromii* starch degradation by cross-feeding, as also suggested by spectrophotometric measurements. These concentrations were comparable to the growth of *R. gnavus* on 0.5% Glc as sole carbon reaching 3 × 10^9^ 16S rDNA copies/mL after 7 h of growth (Figure [1D](#F1){ref-type="fig"}).

The production and utilization of starch degradation products was monitored over time by ^1^H NMR (Figure [2](#F2){ref-type="fig"}). Maltotetraose, maltose and glucose-1-phosphate were detected in the spent medium of *R. bromii* mono- or co-cultures (with SS or RS) and their concentration decreased over time. However, while maltotetraose and glucose-1-phosphate were only detected during the exponential phase, maltose was still present at the late stage of growth in mono-cultures. Glc was also released by *R. bromii* degradation of SS or RS but tended to accumulate in mono-cultures while its concentration decreased over time in the presence of *R. gnavus*. Interestingly, the concentration of these starch degradation products was higher in *R. bromii* mono-culture on SS as compared to RS, which may be due to a slower rate of RS degradation allowing a more efficient uptake of the products.

![Concentration of starch degradation products in the spent media. The concentrations were determined by ^1^H NMR and the values are averages of 2 to 5 replicates. The error bars correspond to standard deviations. Results presented in the blue, red and green boxes come from growth assays with Glc, SS and RS as sole carbon source, respectively. Results from the YCFA medium alone, without carbon source, are presented inside the yellow box. Abbreviations: exp, exponential; sta, stationary; n/a, non-applicable.](fmicb-09-02558-g002){#F2}

In order to determine which starch degradation products were utilized by *R. bromii* and *R. gnavus*, mono-cultures were performed with malto-oligosaccharides and Glc as control. Both strains could utilize maltose, maltotriose and maltotetraose while Glc was only a substrate for *R. gnavus* (data not shown), suggesting that the release of Glc and malto-oligosaccharides upon *R. bromii* starch degradation contributed to *R. gnavus* cross-feeding on SS or RS. These results suggest that both syntrophy and competition could take place when *R. gnavus* and *R. bromii* are co-cultured with starch.

Effect of Starch Co-cultures on Bacterial Metabolism
----------------------------------------------------

Next, we determined the metabolites produced by the bacteria in mono- and co-culture by ^1^H NMR analysis of the spent media. Acetate was the main SCFA produced by both *R. bromii* L2-63 and *R. gnavus* ATCC 29149 in mono- or co-cultures and its production was increased during bacterial growth (Figure [3A](#F3){ref-type="fig"}). No butyrate or propionate was detected in the growth conditions tested. Formate and ethanol were produced in increasing amounts by both *R. bromii* L2-63 and *R. gnavus* ATCC 29149 in mono- or co-cultures during bacterial growth (Figure [3A](#F3){ref-type="fig"}). Propanol was detected at low concentration at the late stage of growth when *R. gnavus* was grown with Glc as well as when *R. bromii* was grown with starch in mono- or co-cultures (Figure [3B](#F3){ref-type="fig"}). Interestingly, propanediol was only produced when *R. gnavus* was present (in mono-culture with Glc or in co-cultures with starch), suggesting that propanol is produced via different pathways in *R. bromii* L2-63 and *R. gnavus* ATCC 29149 (Figure [3B](#F3){ref-type="fig"}).

![Concentration of different metabolites in the spent media. Concentrations of ethanol, formate and acetate are shown in panel **(A)** while concentrations of propane-1, 2-diol and propanol are shown in panel **(B)**. These concentrations were determined by ^1^H NMR and the values are averages of 2 to 5 replicates. The error bars correspond to standard deviations. Results presented in the blue, red and green boxes correspond to growth assays with Glc, SS and RS as sole carbon source, respectively. Results from the YCFA medium alone, without carbon source, are presented inside the yellow box. Abbreviations: exp, exponential; sta, stationary; n/a, non-applicable.](fmicb-09-02558-g003){#F3}

Three main propanol biosynthesis pathways have been identified in bacteria, the propane-1, 2-diol pathway, the acrylate pathway and the Wood-Werkman cycle ([@B31]). These pathways all share the last step, i.e., the conversion of propanal into propanol catalyzed by a propanol dehydrogenase (PduQ). Search for putative enzymes involved in propanol production in *R. gnavus* ATCC 29149 and *R. bromii* L2-63 genomes, identified genes encoding putative PduQ proteins, RUMGNA_01033 and L2-63_01124, respectively. No gene encoding a putative acryloyl-CoA reductase could be found in the genome of these strains, ruling out the acrylate pathway for propanol production in these bacteria. Although both bacteria encode a putative lactaldehyde reductase and a propanol dehydrogenase, PduCDE homologs could only be found in the *R. gnavus* genome indicating that propanol can be produced via the propane-1, 2-diol pathway in this bacterium. This pathway is involved in metabolism of the deoxy-sugars fucose and rhamnose ([@B31]). In addition to PduQ, both bacteria encode homologs of the methylmalonyl-CoA carboxytransferase and propanal dehydrogenase needed for propanol production via the Wood-Werkman cycle (Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}).

Effect of Starch Co-cultures on Bacterial Transcription
-------------------------------------------------------

To gain further insights into the metabolic pathways underpinning trophic interactions between the two strains, transcriptional analyses of *R. bromii* L2-63 and *R. gnavus* ATCC 29149 grown in mono-cultures on starch (RS or SS) or Glc, respectively, or co-cultures on starch (RS or SS) were performed by RNA-Seq. An average of 20 million reads were generated for each sample which is sufficient sequencing depth. In the co-cultures, the reads assigned to *R. bromii* represented on average around 42% of total reads, for both SS and RS. This result correlates well with the bacterial count determined by qPCR where *R. bromii* 16S copies represented 46% and 32% of total 16S copies in SS and RS, respectively. Differential gene expression analysis (DESeq 2) was carried out to determine the influence of the carbon source or of the other bacterium on gene transcription.

Interestingly, the transcription of all *R. bromii* genes was found to be very similar in both mono-cultures irrespective of the type of starch (Figures [4A](#F4){ref-type="fig"}, [5A](#F5){ref-type="fig"}), suggesting that the catabolism of RS or SS shares the same metabolic pathway. For example, the dockerin-carrying amylases Amy4, Amy9, Amy10, and Amy12 GH13 enzymes ([@B44]) were all expressed in the conditions tested in this study. However, the type of starch had an impact on *R. bromii* gene transcription when in co-culture with *R. gnavus*, with 11 genes up-regulated with RS compared to SS, suggesting a combined effect of RS and *R. gnavus* (Figure [5B](#F5){ref-type="fig"}). These genes belong to 3 different clusters: 3 are part of a cluster of genes potentially involved in sugar metabolism, one is the *pduQ* gene which is involved in the conversion of propanal into propanol (see above) and 7 genes (ntpABCDEGK) are involved in the formation of a ntp sodium pump operon encoding Vacuolar-type Na + -translocating ATPase (Figure [6](#F6){ref-type="fig"} and Supplementary Table [S3](#SM1){ref-type="supplementary-material"}). Interestingly, sodium and potassium ion gradients also serve as important energy reservoirs of bacterial cells and could be upregulated due to the competitive stress in the co-culture ([@B26]).

![Principal component analysis (PCA) plots for transcriptomics data of *R. bromii* L2-63 genes **(A)** and *R. gnavus* ATCC 29149 genes **(B)**.](fmicb-09-02558-g004){#F4}

![Volcano plots representing the differential expression analysis of *R. bromii* L2-63 genes. Genes are considered to be differentially expressed when Log2 Fold Change \< --1.5 or \> 1.5 and padj \< 0.05; non-differentially expressed genes are shown as blue dots. The impact of starch on *R. bromii* L2-63 gene transcription in mono-cultures and co-cultures is shown in panel **(A,B)**, respectively. **(A)** No gene was differentially expressed between both mono-cultures. **(B)** When comparing the co-cultures, 11 genes were up-regulated with RS as compared to SS (shown as green dots). The impact of *R. gnavus* ATCC 29149 on *R. bromii* L2-63 gene transcription with SS and RS as sole carbon source is shown in panel **(C,D)**, respectively. **(C)** When SS was used as carbon source, 7 genes were up-regulated in the co-culture as compared to the mono-culture (shown as green dots). **(D)** When RS was used as carbon source, 23 genes were up-regulated in the co-culture (shown as green dots) while 4 genes were upregulated in the mono-culture (shown as red dots).](fmicb-09-02558-g005){#F5}

![Heatmap of the transcription level (in arbitrary unit) of differentially expressed (Log2 Fold Change \< --1.5 or \> 1.5 and padj \< 0.05) *R. bromii* L2-63 genes in different growth conditions. This heatmap was produced with ClustVis web tool ([@B22]) using the transcript counts as input values.](fmicb-09-02558-g006){#F6}

In co-cultures, *R. gnavus* had a greater effect than the type of starch on *R. bromii* gene expression. (Figures [5C,D](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"} and Supplementary Table [S3](#SM1){ref-type="supplementary-material"}). Seven *R. bromii* genes were upregulated in the presence of *R. gnavus* irrespective of the carbon source (Figure [6](#F6){ref-type="fig"} and Supplementary Table [S3](#SM1){ref-type="supplementary-material"}); these genes, which include trpA, B, C, D, E and G, are all involved in the tryptophan biosynthetic pathway and are expressed when tryptophan level is low. In particular trpA, B, C, D, E and G genes were increased by around 13-fold and ninefold in the co-cultures with SS and RS, respectively, as compared to the corresponding mono-cultures. Tryptophan is metabolized by enzymes in the gut mucosa and also by enzymes produced by the gut microbiome. In *R. gnavus* ATCC 29149, RUMGNA_01526 is capable of decarboxylating tryptophan to tryptamine, an activity that is rare among bacteria, and also shared by the common gut Firmicutes member, *Clostridium sporogenes* ATCC 15579 ([@B43]). It is estimated that ∼10% of the human population harbor one of these enzymes. Interestingly, *R. gnavus* genes involved in tryptophan biosynthesis were not differentially expressed between the three conditions tested, which may be due to *R. gnavus* higher capacity to acquire and metabolize tryptophan from the medium. NMR data confirmed that the tryptophan level in the spent medium was lower in the co-cultures as compared to the mono-cultures (data not shown). Together these data suggest that tryptophan may become a limiting factor for *R. bromii* growth on this substrate in the presence of *R. gnavus*. In addition, 16 genes were found to be specifically upregulated in the RS co-culture as compared to the RS mono-culture, including 4 genes belonging to a cluster of genes involved in sugar metabolism (Figure [6](#F6){ref-type="fig"} and Supplementary Table [S3](#SM1){ref-type="supplementary-material"}). It is worth noting that 10 of the 16 genes were also up-regulated in the RS co-culture as compared to SS co-culture. These results further indicate that the observed transcriptional changes in *R. bromii* L2-63 were due to a combined effect of *R. gnavus* and RS.

Interestingly, *R. bromii* showed a down-regulation of the vitamin B12-dependent methionine synthesis genes (metE, metH, metK) in the RS co-culture as compared to the RS mono-culture (Figure [5D](#F5){ref-type="fig"}). The downregulation in co-culture could be due to the lack of sufficient VitB12 (cobalamin) amount in the YCFA growth medium to sustain both *R. bromii* and *R. gnavus* growth as *R. bromii* does not have the ability to produce this vitamin ([@B44]).

The transcription profile of *R. bromii*, indicate the requirement for *R. bromii* to adjust its metabolic activity toward tryptophan and vitamin B12, especially when RS was used as sole carbon source, so that its growth remains unaffected in the presence of *R. gnavus* as shown above.

*Ruminococcus gnavus* ATCC 29149 showed a much higher number of differentially expressed genes between mono- and co-cultures as compared to *R. bromii* (Figure [7](#F7){ref-type="fig"}), especially with RS (Figure [4B](#F4){ref-type="fig"}). A total of 22 genes were down-regulated in both co-cultures compared to the mono-culture whereas 20 were upregulated including genes encoding several maltose transporters and enzymes involved in degradation of starch-related products such as RUMGNA_01664 to 01673 and RUMGNA_02728 to 02733 (Figure [8](#F8){ref-type="fig"} and Supplementary Table [S4](#SM1){ref-type="supplementary-material"}). These results are in agreement with the NMR findings showing that *R. gnavus* can utilize malto-oligosaccharides as sole carbon source and from the qPCR analysis showing that *R. gnavus* can efficiently cross-feed on starch-degradation products when grown with *R. bromii*. The fact that, upon *R. bromii* starch degradation, *R. gnavus* benefits from Glc (which is not a substrate for *R. bromii*) may explain why *R. bromii* transcription is not affected on SS (a rapidly degradable starch) in co-culture as this will serve as a preferential nutrient source for *R. gnavus*. However, the ability of *R. gnavus* to utilize malto-oligosaccharides, which is a major nutrient source for *R. bromii* suggests a direct competition between the two strains, which is reflected by *R. bromii* transcriptomics data on RS. This is corroborated by the results of starch degradation products in the spent media (Figure [2](#F2){ref-type="fig"}) which showed Glc presence in SS co-culture medium compared to the absence of Glc in the slow degrading RS co-culture medium.

![Volcano plots representing the differential expression analysis of *R. gnavus* ATCC 29149 genes. Genes were considered to be differentially expressed when Log2 Fold Change \< --1.5 or \> 1.5 and padj \< 0.05; non-differentially expressed genes are shown as blue dots. Panel **(A)** shows the impact of starch type on *R. gnavus* ATCC 29149 gene transcription when co-cultured with *R. bromii* L2-63; 213 genes were upregulated in the co-culture with RS (shown as green dots) while 212 genes were up-regulated in the co-culture with SS (shown as red dots). The combined effect of the presence of *R. bromii* L2-63 and the carbon source (starch vs. glucose) is shown in panels **(B)** and **(C)** when SS or RS was used in the co-culture, respectively; **(B)** When SS was used as carbon source, 40 genes were up-regulated in the co-culture (shown as green dots) and 59 genes were up-regulated in the mono-culture (shown as red dots). **(C)** When RS was used as carbon source, 119 genes were up-regulated in the co-culture (shown as green dots) while 101 genes were up-regulated in the mono-culture (shown as red dots).](fmicb-09-02558-g007){#F7}

![Heatmap of the transcription level (in arbitrary unit) of selected differentially expressed (Log2 Fold Change \< --1.5 or \> 1.5 and padj \< 0.05) *R. gnavus* ATCC 29149 genes in different growth conditions. This heatmap was produced with ClustVis web tool ([@B22]) using the transcript counts as input values. The 20 *R. gnavus* ATCC 29149 genes with an upregulated transcription in both co-cultures with *R. bromii* L2-63 on starch compared to the mono-culture on Glc are in blue. The 22 *R. gnavus* ATCC 29149 genes with an upregulated transcription in the mono-culture on Glc compared to both co-cultures with *R. bromii* L2-63 on starch are in black.](fmicb-09-02558-g008){#F8}

In summary, we showed that, *in vitro*, *R. gnavus* can efficiently cross-feed on starch degradation products released by *R. bromii*. Cross-feeding plays a crucial role in microbial community shaping in the gut ([@B15]). This concept involves the ability of bacteria to benefit from substrate degradation products but also from fermentation products and/or cofactors. For example, *Anaerostipes caccae* L1-92 can utilize both mucin sugars and acetate produced by mucin degradation by *Akkermansia muciniphila* ATCC BAA-835 to sustain its growth and produce butyrate ([@B7]). Here, we showed that *R. bromii* L2-63 could not benefit from degradation products or metabolites released by *R. gnavus* ATCC 29149 grown on mucin, in line with the unique genomic characteristics of *R. bromii* strains sequenced to date ([@B25]) and the mucin foraging profile of *R. gnavus* strains ([@B8], [@B9]). However, we showed that RS cross-feeding initiated by *R. bromii* promoted growth of *R. gnavus* leading to the concomitant production of acetate as the main SCFA produced by these strains. Cross-feeding of gut bacteria on starch degradation products has previously been reported *in vitro* between starch degrader *R. bromii* or *Bifidobacterium longum* subsp. *suis* and bacterial species, potentially sharing the same nutrient niche in the gut such as *Anaerostipes hadrus* ([@B46]) or *B. thermacidophilum* subsp. *porcinum* ([@B23]), respectively. Resource sharing is an important ecological feature of microbial communities living in the gut ([@B37]; [@B29]; [@B6]). The findings from our study suggest that, although *R. gnavus* strains are adapted to the mucosal environment owing to their mucin-foraging capacity ([@B8], [@B9]; [@B36]; [@B28]), their population dynamics within the colon may also be affected by the supply of dietary carbohydrates that reaches the large intestine undigested such as RS. Due to the high prevalence of *R. bromii* in the human colon, the hydrolysis of RS will cause the release of nutrients such as glucose or metabolites that may reach bacterial species within the mucus layer, potentially promoting the growth of other species to occur, thereby further underscoring the role of *R. bromii* as a keystone species. These findings open the door to future efforts to explore cross-feeding activities between different nutrient niches *in vivo* and the use of RS or other complex polysaccharides as a strategy to address dysbiosis of mucus-associated bacteria associated with human diseases.
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